Ong, Sally S. http://orcid.org/0000-0003-3599-9021
Proia, Alan D.
Whitson, Heather E.
Farsiu, Sina
Doraiswamy, P. Murali
Lad, Eleonora M.
Funding for this research was provided by:
Alzheimer’s Association
Duke Institute for Brain Sciences, Duke University
National Eye Institute
International Retinal Research Foundation
U.S. Department of Veterans Affairs
National Institute on Aging
Duke University
National Institutes of Health
Avid/Lilly
Anthrotonix
Muses Labs
AstraZeneca Schweiz
Cognoptix
Lundbeck/Takeda
Piramal
Genomind
Sonexa
Targacept
NeuroPro
Neurocog Trials
Forum
Holmusk
T3D Therapeutics
Elan
Avanir
Neuronetrix
Alzheimer’s Drug Discovery Foundation
University of Southern California
ADCS/UCSD
Hintsa Performance
Crossings
Physicians Postgraduate Press
Maxwell Health
Evidation
Adverse Events Inc
Pfizer
World Economic Forum
Article History
Received: 1 June 2018
Revised: 18 August 2018
Accepted: 20 August 2018
First Online: 28 August 2018
Compliance with ethical standards
:
: SSO receives research funding from the International Retinal Research Foundation. EML has received research grants from Alzheimer’s Association, Duke Institute for Brain Sciences and the National Eye Institute. HEW has received research grants from the Veterans Affairs Medical Center, National Institute on Aging and Alzheimer’s Association. SF has received research grants from the National Institute of Health and Duke University, and holds US patent 8811745 and 9299155. PMD has received advisory fees from Avid/Lilly, Anthrotronix, Muses Labs, AstraZeneca, Cognoptix, Lundbeck/Takeda, Piramal, Genomind, Sonexa, Targacept, NeuroPro, Neurocog Trials, Forum, Holmusk, and T3D Therapeutics; research grants (through Duke University) from Elan, Avid/Lilly, Avanir, Neuronetrix, Forum, Alzheimer’s Drug Discovery Foundation, USC, and ADCS/UCSD; fees for lectures from Hintsa Performance, Crossings; and fees for developing educational materials from Physicians Postgraduate Press. PMD owns shares or options in Maxwell Health, Muses Labs, Anthrotronix, Evidation, and Adverse Events Inc (whose products are not discussed here), and has received travel funds from Pfizer and the World Economic Forum. ADP reports no competing interests.
: This articles does not contain any studies with human participants performed by any of the authors.